Every junior analyst learns all three methods. Most can build all three models. Very few understand why a seasoned MD will look at a football field chart showing three different valuation ranges and immediately know which one to anchor the conversation on — and which two are there for context.
The textbook answer is that you use all three and present a range. That answer is correct and incomplete. In a live deal, someone has to decide which method carries the most weight when they diverge. That decision is not arbitrary, and it's not made by averaging. It's made by understanding what each method is actually measuring, which conditions make each reliable, and what the divergence between methods is telling you about the specific asset being valued.
The Fundamental Misunderstanding About Valuation Methods
Most people learn the three methods as three routes to the same destination. They aren't.
DCF, Comparable Company Analysis, and Precedent Transactions answer three fundamentally different questions:
DCF answers: What is this business worth based on the cash flows I believe it will generate, discounted at a rate that reflects the risk of those cash flows materialising?
Comps answer: What are investors currently paying for similar businesses trading in public markets?
Precedents answer: What have acquirers historically paid to control similar businesses in negotiated transactions?
These are not the same question. The first is a fundamental value question — it depends entirely on your projection assumptions. The second is a market pricing question — it reflects current sentiment, liquidity conditions, and sector multiples. The third is an acquisition pricing question — it reflects control premiums, strategic rationale, and deal-market conditions at specific historical moments.
When all three agree, your analysis has convergent support and the range is narrow. When they diverge significantly — and they often do — the divergence is not a problem to be resolved by averaging. It's information about the market versus fundamental value gap, the deal market versus public market premium, or the assumption sensitivity embedded in your projections.
Senior bankers read divergence as signal. Junior analysts treat divergence as noise to be explained away.
When DCF Is the Primary Method — and When It's Dangerous
DCF is the most intellectually defensible valuation method when used correctly. It's also the most manipulable, the most assumption-sensitive, and the most commonly misapplied.
When DCF should anchor the analysis:
Scenario 1: No meaningful comparables exist
A private equity firm is evaluating the acquisition of a vertically integrated specialty chemicals company. The company has a unique combination of proprietary processes, long-term take-or-pay contracts with industrial clients, and a cost structure that doesn't match any publicly traded pure-play. The closest public comparables are 40% larger, operate in adjacent sub-sectors, and trade on metrics that don't translate cleanly.
Here, a comps analysis would produce a range so distorted by peer selection compromises that it would be analytically misleading. The DCF, built on the company's actual contract structure, known capacity expansions, and audited margin history, produces the most defensible valuation.
Scenario 2: The business is in transition
A consumer technology company is transitioning from a hardware-led revenue model to a subscription software model. Current EBITDA is negative or depressed by the investment required for the transition. Public market comps are either pre-transition hardware companies or post-transition software companies — neither reflects the company at this specific point in its evolution.
A DCF that models the transition explicitly — declining hardware revenue, growing subscription revenue, the margin expansion that follows as software revenue scales — captures the investment thesis better than any multiple applied to current-year metrics.
Scenario 3: Long-duration infrastructure or asset-heavy businesses
Utilities, pipelines, long-term infrastructure assets, and regulated businesses have relatively predictable long-duration cash flows. Applying multiples to these businesses introduces unnecessary noise. The DCF models the contracted or regulated cash flow stream directly.
When DCF becomes unreliable — the honest constraints:
-
Terminal value dominates: In most 5-year DCFs, 60-75% of enterprise value sits in the terminal value. You're not really modelling cash flows; you're arguing about an exit multiple or perpetuity growth rate. The precision of five years of projected income statements is largely decorative.
-
WACC sensitivity is extreme: Moving WACC by 100 basis points in either direction changes enterprise value by 15-25% in most models. WACC is less a calculated number than a judgment call with mathematical formatting.
-
Garbage in, gospel out: The most common DCF failure is anchoring projections on management's base case and presenting the output as an objective analysis. Management projections are structurally optimistic in sell-side processes.
-
Circular on terminal value: If your terminal value uses an exit multiple derived from current market comps, you've embedded the comps analysis inside your DCF. Many practitioners don't realise this.
When Comparable Company Analysis Should Lead — and Its Hidden Distortions
Comps is the workhorse of investment banking valuation. It's fast to build, easy to update, and immediately anchored to current market conditions. It's also the method most routinely distorted by peer selection bias — the practice of choosing comparables that support a preferred outcome rather than the most analytically appropriate ones.
When comps should anchor the analysis:
Scenario 1: Liquid public market with genuine comparables
A consumer staples company is considering the sale of a branded beverage division. The division generates $85M in EBITDA, has stable 3-4% organic growth, and operates in a sector with 15-20 genuinely comparable publicly traded companies with consistent trading liquidity and similar business model characteristics.
Here, the market has efficiently priced similar assets. Buyers know exactly what they're willing to pay relative to public comparables. A DCF adds intellectual rigour but introduces assumption sensitivity that doesn't exist in the simpler multiple analysis.
Scenario 2: Asset-light, multiple-driven sectors
Technology, media, and certain consumer sectors are priced primarily on multiples in practice. A PE buyer acquiring a SaaS company is thinking in terms of ARR multiples and Rule of 40 scores, not DCF terminal values. Building a primary case around a DCF in a sector where buyers price on multiples produces a valuation that's analytically defensible but commercially irrelevant.
The peer selection problem — what nobody explains clearly:
The comps analysis looks objective because it's based on public market data. But the selection of which companies are in the peer group is the most subjective and most consequential choice in the analysis.
In a sell-side process, the natural pressure is to include peers that trade at higher multiples. In a buy-side process, the natural pressure is the reverse. Neither is necessarily dishonest — there are legitimate arguments for many reasonable peer selections. But the analyst who presents a comps table without acknowledging the selection sensitivity is presenting false precision.
The test for peer selection integrity:
Remove the two highest-multiple companies from the peer group. Remove the two lowest. Does the implied valuation range change materially? If yes, the analysis is sensitive to specific peer inclusion decisions that should be disclosed and discussed.
When comps distorts reality:
-
Sector dislocation: In 2022, rising rate pressure caused a significant re-rating of high-growth technology companies. Comps built in Q4 2021 showed enterprise value multiples that were 40-60% higher than comps built in Q2 2022. Neither set of comps was wrong — both reflected market conditions accurately. But applying Q4 2021 comps to a Q2 2022 transaction would have produced materially misleading guidance.
-
Size and liquidity gaps: Applying multiples from $5B+ revenue public companies to a $200M revenue private company ignores the size premium embedded in large-cap multiples — larger companies trade at premium multiples that reflect diversification, scale advantages, and index inclusion that smaller companies don't share.
When Precedent Transactions Should Lead — and the Timing Problem
Precedents occupy a specific analytical role: they represent what acquirers have actually paid for control of comparable businesses in completed deals. They answer a different question than comps — not what public investors are paying for minority positions, but what strategic and financial buyers have paid to acquire controlling stakes.
This control premium — typically 25-40% above unaffected trading price in public company deals — is embedded in precedent multiples by definition. This makes precedents the most directly relevant method when you're valuing a business for an acquisition.
When precedents should anchor:
Scenario 1: Sell-side advisory in a well-precedented sector
A healthcare services company is running a sale process. The sector has 15-20 completed transactions in the last three years, with deal multiples in a consistent range reflecting the strategic value acquirers place on scale, geographic coverage, and contract relationships. In this case, precedents from comparable healthcare services transactions give the most directly relevant answer: this is what buyers have actually paid for businesses like this one.
The timing problem that invalidates many precedent analyses:
Transaction multiples are time-stamped. They reflect the deal market conditions — interest rates, credit availability, strategic appetite, and risk tolerance — at the time the deal closed. A precedent transaction from Q3 2021, when credit was cheap, strategic M&A was aggressive, and risk appetite was high, reflects conditions that may have no relevance to a 2024 deal process.
How practitioners handle this:
- Weight recent transactions (last 18-24 months) more heavily than older ones, but always present the full dataset with dates visible
- Note explicitly when rate environments at transaction dates differ materially from current conditions
- When the most relevant transactions are more than 24 months old, use precedents as a directional reference rather than a primary anchor
The structural difference nobody explains:
Precedent multiples in strategic M&A transactions include synergy value — the buyer is paying not just for the target as it is, but for the combined entity's enhanced value. Comps multiples include no synergy value — public investors are pricing the standalone business.
This means: precedents will almost always be higher than comps on the same target, in the same conditions. Presenting both without explaining the structural reason for the gap implies the gap is market mispricing. It isn't — it's the structural price of control and the capitalisation of expected synergies.
The Football Field Chart: How Practitioners Present All Three Together
The football field — a horizontal bar chart showing the implied valuation range from each method — is the standard presentation format for multi-method valuation. But the way it's built and the way it's read by senior practitioners is different from the way most analysts are taught to use it.
How it's taught: Build all three methods, put them on the football field, present the overlap as the "fair value range."
How senior practitioners actually use it:
The football field is a diagnostic tool before it's a presentation tool. When building it, experienced bankers look for three things:
1. Convergence: Do the three methods produce overlapping ranges? Convergence — when DCF, comps, and precedents all point to a similar valuation range — is the strongest possible analytical outcome. It means fundamental value, market pricing, and deal market pricing are aligned.
2. Systematic divergence in one direction: If DCF consistently shows a higher value than comps and precedents, the most common explanations are: management projections are too aggressive, the discount rate is too low, or the market is pricing in execution risk that the model doesn't capture.
If comps show significantly higher values than both DCF and precedents, the sector is likely in a bull market condition where sentiment has outrun fundamentals — 2021 tech multiples being the canonical example.
3. The overlap zone as the anchor: When methods diverge, the overlap region — the range where two or more methods agree — becomes the defensible anchor for deal pricing.
Method Selection by Context: The Decision Matrix
The choice of primary method is determined by the deal context, the company characteristics, and the market conditions at the time of the analysis.
Buy-side advisory: The buyer needs to know what the asset is worth to them, including synergies, and whether the asking price is justified. Primary method: DCF incorporating synergies plus comps to understand market pricing context. Precedents provide the ceiling — they represent what others have been willing to pay, not what this specific buyer should pay.
Sell-side advisory: The seller needs to maximise price and demonstrate to the board that the deal price is fair. Primary method: Precedents (they show what buyers have paid for comparable businesses) plus comps (current market anchor). DCF is supporting — it provides fundamental value context but shouldn't be the anchor in a sell-side process where management projections are typically optimistic.
Fairness opinion: The board needs an independent determination that the deal price is fair to shareholders. All three methods are presented, the overlap zone is identified, and the opinion is based on whether the deal price falls within or above the defensible range.
LBO analysis: Financial buyers need to determine what price they can pay to generate target returns at appropriate leverage. DCF is recast as an LBO model with debt schedule, covenant analysis, and exit multiple scenarios.
The Sector Conventions Nobody Teaches You
Beyond the general framework, each sector has entrenched valuation conventions that practitioners follow not because other methods are theoretically wrong, but because the conventions reflect the metrics buyers and sellers in that sector actually use.
Technology and SaaS: ARR multiples and EV/Revenue, not EV/EBITDA. Using EBITDA-based multiples on a pre-profitability SaaS company signals unfamiliarity with the sector.
Financial Services (Banks and Insurance): Price/Book Value (P/BV) and Price/Tangible Book Value (P/TBV) are the primary metrics. Using EV/EBITDA multiples on a bank is a technical error.
Real Estate: Cap rate (NOI/Value) and NAV (Net Asset Value) are the primary valuation frameworks.
Oil and Gas: EV/EBITDAX (adds back exploration expense) and asset-level NAV based on reserve valuation. The primary assumption is the commodity price deck.
Healthcare Services: EV/EBITDA with adjustments for regulatory reserve requirements and government reimbursement exposure.
Reading the Divergence: What It's Actually Telling You
When your football field shows wide divergence — DCF at $1.1B and comps at $700M — the instinct is to find a narrative that explains it.
DCF significantly above comps:
The model assumes the company will perform materially better than the market expects for comparable businesses. Either you've identified a specific value-creation driver the market hasn't priced (legitimate investment thesis), you're anchoring on overly optimistic management projections (common in sell-side), or your discount rate is too low.
Diagnostic: stress-test the DCF to match the comps multiple. What growth rate and margin assumptions are implied by the market multiple? Are those assumptions unreasonable for this business?
Comps significantly above DCF:
The market is pricing in expectations that your model doesn't capture — either near-term catalyst anticipation, sector sentiment premium, or liquidity-driven multiple expansion. In a buy-side context, this divergence is a caution signal. In a sell-side context, it's an opportunity.
Precedents significantly above both comps and DCF:
The deal market is paying premiums that go beyond both current market pricing and fundamental value. Either synergies are material enough to justify the premium for strategic buyers, or the historical precedents reflect a deal market that has since corrected.
Closing: Valuation Methodology Is One Skill Inside a Complete Deal Toolkit
Knowing when to use DCF versus comps versus precedents — and how to read the divergence between them — is foundational analytical work. But in a live deal, it's one skill set inside a much larger analytical and professional toolkit that practitioners develop over years of transaction exposure.
After mastering the method selection decision, the questions that follow are equally complex: How do you build LBO models that incorporate realistic debt schedules, covenant constraints, and exit timing scenarios? How do you construct and defend a fairness opinion in front of a board that has competing interests? How do you handle the specific valuation challenges in distressed situations?
At Meritshot, the Investment Banking programme is built around exactly this kind of layered deal competency — starting with valuation mechanics, moving through transaction structuring, capital markets conventions, and the professional judgment that distinguishes a technically correct analysis from one that actually drives a deal outcome.
Explore the Meritshot Investment Banking Programme →
This article was written by the Meritshot content team. Meritshot trains professionals in Data Science, AI Engineering, Full Stack Development, Investment Banking, and Cyber Security through hands-on, practitioner-led programmes.
